	Alzheimer's disease blood-based biomarkers in the Boston Latino Aging Study (BLAST): Associations with cognition and depressive symptoms. medRxiv Tristão-Pereira C, Silva G, Lopez KA, Ku V, Gonzalez A, Martinez JE, Giudicessi A, Rowe M, Garcia S, Catalan MG, Saldana DG, Gatchel J, Ramirez-Gomez LA, Quiroz YT. PMID: 42999263 [PubMed]
	Single-cell and spatial transcriptomic insights into neural substrates of Behavioural dysfunction in Alzheimer's disease. Mol Cell Neurosci Mondal S, Sharma N, Mishra N. PMID: 42998805 [PubMed - as supplied by publisher]
	Efficacy and safety of anti-tau drugs for Alzheimer's disease: A systematic review and network meta-analysis. J Prev Alzheimers Dis Hu Y, Cheng Y, Su Y, Han Z, Shen X, Hu H, Wang Q, Wan S, Li H, Zhang N. PMID: 42998661 [PubMed - as supplied by publisher]
	Effectiveness of Verbal Fluency Tests for Detecting Cognitive Decline in Adults with Alzheimer's Dementia and Frontotemporal Dementia: A Three-Level Meta-Analysis. Neuropsychol Rev Chang CYG, Foran AM, Cheung MW. PMID: 42998135 [PubMed - as supplied by publisher]
	Study on the topological features of cortical morphological similarity networks in Alzheimer's disease of different cognitive states. Quant Imaging Med Surg Zhu X, He J, You J, Lin J. PMID: 42997919 [PubMed]
	GLP-1 receptor agonists as potential disease-modifying agents in Parkinson's and Alzheimer's disease: mechanisms, clinical trial evidence, and the neuroprotection horizon. Front Aging Neurosci Alsharif M, Shrebaty O, Aloudah MA, Alqahtani M, Aloubili RS, Ahmed MJ, Albani B, El Bana A. PMID: 42997320 [PubMed]
	Reprogramming the gut-brain axis in neurodegeneration: comparative microbiome, metabolite, immunometabolic, polyphenol, probiotic, and epigenetic mechanisms in Alzheimer's and Parkinson's diseases. Front Aging Neurosci Cheng YJ, Tao MP, Qian K, Ye W. PMID: 42997004 [PubMed]
	Global, regional, and national burden of anxiety-related Alzheimer's disease and Alzheimer's-related dementias among older adults from 1995 to 2021: A comparative risk assessment study. Alzheimers Dement (Amst) Ying J, Zhou J, Shan S, Liu X, Zhu L, Xu C, Luo Z, Wu J, Song P. PMID: 42996801 [PubMed]
	Blood TRPC6 mRNA as a biomarker for Alzheimer's disease: a nationwide, multicenter study in China. Alzheimers Dement (Amst) Pu M, Wen Y, Chen Y, Wang J, Pan X, Wang G, Li X, Wang G, Zuo C, Shi J, Zhu L, Wu J, Ren R, Cheng X, Zhang S, Wang J, Liu S, Li L, Huang F, Ding D, Guan Y, Zhong C, Zhao Q, Wang Y. PMID: 42996798 [PubMed]
	Neuroinflammation in Alzheimer's disease: pathogenic signaling, biomarkers, and emerging therapeutic interventions. Front Oncol Poonam, Rana R, Thakur M, Sharma A, Pannu S, Sharma S, Naman S, Rani S, Devi D, Kumar V, Kumar S. PMID: 42996505 [PubMed]
	Plasma neurofilament light links mortality to neuroaxonal injury beyond clinical decline and Alzheimer disease plasma biomarkers: a multi-cohort study of oldest old individuals. medRxiv Lorenz LMC, Sikkes SAM, Heymans MW, Hulsman M, Tesi N, Gouda M, Graat MJI, van der Hoorn ME, Daatselaar DAH, Christensen K, Thinggaard M, Teunissen CE, Holstege H. PMID: 42996243 [PubMed]
	A digital biomarker of white-matter routing from diffusion MRI as an early biomarker of Alzheimer's disease. medRxiv Ghodrat M, Schlachetzki JC, Alzheimer. PMID: 42996215 [PubMed]
	Glycogen Synthase Kinase-3Î² as a Central Regulator of Alzheimer's Disease: Mechanistic Insights and Therapeutic Perspectives. Eur J Neurosci Kifayat S, Kifayat W, Chauhan SK, Zehra A, Kaushik R, Najmi AK, Parvez S, Ali J, Akhtar M. PMID: 42995462 [PubMed - indexed for MEDLINE]
	Single-cell and spatial transcriptomics of cellular heterogeneity in Alzheimer disease. Nat Rev Neurosci Emerson N, Vallejo K, Rahimzadeh N, Kwang NE, Swarup V. PMID: 42995230 [PubMed - as supplied by publisher]
	Lecanemab in Singapore: Appropriate use recommendations for early Alzheimer's disease. Ann Acad Med Singap Chen CL, Kandiah N, Kumar S, Lee KE, Liew TM, Ng ASL, Ng KP, Tay LBG, Ting SKS. PMID: 42995156 [PubMed - as supplied by publisher]
	Corrigendum to "Characterization of local white matter microstructural alterations in Alzheimers disease: A reproducible study" [Comput. Biol. Med. 179, (2024), 108750]. Comput Biol Med Wen C, Zeng Q, Zhou R, Xie L, Yu J, Zhang C, Wang J, Yu Y, Gu Y, Cao G, Feng Y, Wang M. PMID: 42995069 [PubMed - as supplied by publisher]
	[Donanemab in Early Symptomatic Alzheimer's Disease: Navigating Divergent Evidence Standards Between Regulatory Approval and Added-Benefit Assessment (AMNOG)]. Fortschr Neurol Psychiatr Zschocke J, Vöglein J, Dichter S, Heisser T, Maurer P, Doerr M, Scharf M, Opalka J, Perneczky R, A Onur O. PMID: 42994417 [PubMed - as supplied by publisher]
	Molecular mechanisms of lithium neuroprotection in Alzheimer's disease: A systematic comprehensive review. J Trace Elem Med Biol Murthy MK. PMID: 42994329 [PubMed - as supplied by publisher]
	Brain Region-Specific Peptide and Proteomic Signatures Inform Alzheimer's Disease Biomarker Panels. J Proteome Res Sánchez-Pérez M, Osorio-Murillo JP, Martínez-Oviedo A, Ovando-Vázquez C. PMID: 42992893 [PubMed - indexed for MEDLINE]
	Age-linked biological context shapes adaptive immunity in Alzheimer's disease. Alzheimers Dement Shirenova S, Biragyn A, Okun E. PMID: 42992662 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 73071

Page 1 of 3654



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy